Maravai LifeSciences Holdings Inc (MRVI)

42.99 +1.50  +3.62% NASDAQ Nov 29, 11:15 USD

Maravai LifeSciences Holdings Cash from Financing (Quarterly):

-34.35M for June 30, 2021
View 4,000+ financial data types
View Full Chart

Cash from Financing (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Cash from Financing (Quarterly) Data

View and export this data going back to 2020. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2021 -34.35M
March 31, 2021 -24.20M
Dec. 31, 2020 40.67M
Sept. 30, 2020 -0.943M
June 30, 2020 -0.856M
March 31, 2020 14.34M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Benchmarks

Arrowhead Pharmaceuticals Inc 0.815M
Cassava Sciences Inc 0.075M
Agios Pharmaceuticals Inc -250.98M

Cash from Financing (Quarterly) Range, Past 5 Years

Minimum -34.35M Jun 2021
Maximum 40.67M Dec 2020
Average -0.8897M





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.